US regulators approve experimental drug Remdesivir for emergency use for coronavirus patients, days after study showed it may help the worst-hit .
US may approve emergency use of Ebola drug remdesivir TODAY - as Oxford expert hails trial as 'fantastic result and great news for the fight against Covid-19'
US may approve emergency use of Ebola drug remdesivir TODAY - as Oxford expert hails trial as 'fantastic result and great news for the fight against Covid-19'
Remdesivir, an antiviral made by California-based Gilead Sciences, was shown to slash recovery times in a global trial of more than 1,000 patients, including Britons. Anthony Fauci, America's top infectious disease expert, told yesterday's White House briefing: 'What it has proven is that a drug can block this virus.' Echoing those sentiments, Peter Horby, Professor of Emerging Infectious Diseases at the Oxford, and chair of the Government's Nervtag committee which assesses disease threats, told The Times it was a 'fantastic result and great news for the fight against Covid- 19.'
